Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia - Wikidata - wikimedia - TriplyDB

Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia

Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q28306913

about

Role of microRNA-26b in glioma development and its mediated regulation on EphA2 NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia Comparative expression profiling identifies differential roles for Myogenin and p38α MAPK signaling in myogenesis NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity.Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways.Identification of genes differentially expressed in myogenin knock-down bovine muscle satellite cells during differentiation through RNA sequencing analysis.Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma.NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies Novel functions for small RNA molecules.Hoxb8 regulates expression of microRNAs to control cell death and differentiation.Highly ordered architecture of microRNA cluster MicroRNAs as a therapeutic target for cardiovascular diseases MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.miRNAs as molecular biomarkers of cancer.NKL homeobox genes in leukemia.Understanding the role of miRNA in regulating NF-κB in blood cancer.Noncoding RNAs as epigenetic mediators of skeletal muscle regeneration.Involvement of MicroRNA in T-Cell Differentiation and Malignancy Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.T-ALL and thymocytes: a message of noncoding RNAs NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.MicroRNA expression and activity in T-cell acute lymphoblastic leukemia.Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles.NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells.Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia.Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.

P2860

Q21135751-F7FD0111-5174-4B23-8961-99AF826728F4 Q24300295-CB9439E6-1DA0-450B-939A-DB8B96F37C33 Q27003271-0139E879-992A-48A3-99EC-6800CCECB13A Q27022808-3B3FD0A7-97D9-4813-9A9F-656D32737A65 Q28260580-501E5FE8-850B-4CBB-B2B9-5C160F61DACD Q29347275-527BEE6D-4F96-411B-A0CB-BCAF2C692045 Q30361778-A324BDF1-FE41-466A-A2D9-18B6AECCB236 Q33839512-BF5CADD3-42BA-489C-B45A-42AB54C522CA Q33911452-5AFF62A1-89A5-4D16-9987-EAD8FBABE5FE Q33951701-6758FEC1-C2C9-4038-A8AD-BA94C0910E10 Q34605730-103B05A3-38F7-47D8-A1A3-980AFB310294 Q35028282-842F7282-EE8A-45E8-912B-B9CFB99FEBBD Q35125183-145AAB8A-86BA-4D97-B61E-EBE21149BA48 Q35554311-D44C68A3-F268-4EE0-B96D-33AAB4A608DE Q35677697-B0CF5100-5456-452D-B6C1-493688FA93C2 Q36267574-5F31E1F7-964E-493E-B503-EED92696E8A9 Q36602853-5AE00C0D-6C64-49DF-B744-86E3AFFC357A Q36673371-98EE9514-89B9-4E2B-B380-949BC10D7DA7 Q37163718-A3BC58A2-D359-4520-A792-79DB3106F7C6 Q37250090-510EBCCF-25B2-403A-A0D1-7F9D0B9C8C42 Q37294704-EDE5B7E9-3B9C-4453-ACF1-3DE73D6C499A Q37724950-8953EBFC-C059-4D39-9161-80477587B4C8 Q37750843-6340728A-2FAE-4B7D-9265-192048E72406 Q37957618-F0B36F98-BF62-45DF-B288-F4CCE9E581A8 Q37972140-D459180C-D642-4677-9BF6-694722269057 Q38284580-0E9B68C6-2CBC-4D1B-8259-67A19FC0F8F5 Q38388753-A847C772-71FB-4E4F-BE6D-61A04F2536C1 Q38702262-9AE20E94-94DD-4109-8489-A7F0E0388152 Q39166891-39669EEE-3F3C-4A12-8CEC-A331286066FC Q42366512-08E7A2C1-8892-4B6B-87B9-64744E47D886 Q42417341-D192F0BE-6DA8-4703-A511-8D55E89ABC3A Q49426279-37FF92D7-CA18-40C1-85E8-2FAD0A402593 Q54188397-F2081B68-90CB-4741-8D9B-05F01C87D3FD Q54278747-ACC018F4-098D-4D12-86AA-6F52B6EF903C Q54974772-888A07FE-5932-4AA7-A4D0-00D2C34BAA48 Q55281297-B151C7AE-635E-422E-8537-173AA8CC8C17

P2860

Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q28306913

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@ast

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@en

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@nl

type

label

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@ast

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@en

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@nl

prefLabel

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@ast

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@en

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@nl

P1433

Q28306913-7CFA73DD-6177-4926-8498-518D5CA045C6

P1476

Q28306913-46509376-913B-4573-8F31-34C22A3BF30B

P2093

Q28306913-08EC23B9-7076-4639-98F0-49BBED8ECC7F

Q28306913-52032EF6-3E8F-45AD-92D4-0A6557C9733D

Q28306913-59C054BA-57B9-4C5D-803A-A53A08A07385

Q28306913-760E418B-EC5B-42B6-8DBB-0617F4DA3AD8

Q28306913-89B84411-296E-4CE9-B418-9C914B592B0B

Q28306913-BA53BBA0-0399-4147-A15F-2C4426E2FAC2

Q28306913-D89D1E5F-ED5E-4A30-92CD-1F195B96FC19

Q28306913-F3C5AE5E-3FF3-45E2-BAA7-5D8F995784A8

P2860

Q28306913-00CBAD73-8D50-4518-971A-83ED3E3DB568

Q28306913-02EDAB63-B6DA-4C87-9520-4DDB2E422986

Q28306913-0CFDA60E-4AC4-4260-AACC-97CBF7DF28B1

Q28306913-0FB5AB2F-917E-471C-8E56-64452DC4A326

Q28306913-13D0E5AB-B3B4-4191-A473-46B0F68D34AA

Q28306913-18E769CB-595B-4810-B61E-57485222C6E1

Q28306913-1BF7E97A-3FA6-446C-832A-D80069E460AB

Q28306913-24274E52-F862-4681-AD3B-A484C0E8DA1D

Q28306913-24283D72-D42F-4A01-83E2-C60077660739

Q28306913-261B208C-50BC-423B-8144-3FADBF30377D

P304

Q28306913-7EDF95AE-4917-41E4-A73B-CEC4156B4FFB

P31

Q28306913-3B58116C-963D-43E2-BCB4-846AB98606DF

P356

Q28306913-B0D7DA1A-2290-465F-A325-EB3CE3CBA478

P407

Q28306913-E0352CDC-D90B-43A5-A7E2-9D899BCADB6E

P433

Q28306913-6B740597-3893-4935-9738-F0683E34031F

P478

Q28306913-41B59A6B-B5C3-4AF2-82C7-D12F19A1DB16

P50

Q28306913-7C0EC87F-5108-469B-B706-662E0D45689C

P577

Q28306913-4CBD7C69-DBEE-4F23-865B-BC9B97F7D3E8

P698

Q28306913-99195827-B9F1-49CB-B4BA-52CB90616913

P921

Q28306913-44105F6E-DDEE-455B-920F-F1F0312D9FBE

P356

10428190802626632

P1433

Leukemia & Lymphoma

P1476

Activation of miR-17-92 by NK- ...... l acute lymphoblastic leukemia

@en

P2093

Christian A Schmidt

http://www.w3.org/2001/XMLSchema#string

Corinna Meyer

http://www.w3.org/2001/XMLSchema#string

Grzegorz K Przybylski

http://www.w3.org/2001/XMLSchema#string

Letizia Venturini

http://www.w3.org/2001/XMLSchema#string

Michaela Scherr

http://www.w3.org/2001/XMLSchema#string

Piotr Grabarczyk

http://www.w3.org/2001/XMLSchema#string

Roderick A F Macleod

http://www.w3.org/2001/XMLSchema#string

Stefan Nagel

http://www.w3.org/2001/XMLSchema#string

P2860

MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters

G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Prediction of mammalian microRNA targets

Silencing of microRNAs in vivo with 'antagomirs'

c-Myc-regulated microRNAs modulate E2F1 expression

MicroRNA expression profiles classify human cancers

Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia

A microarray model system identifies potential new target genes of the proto-oncogene HOX11

P304

101-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190802626632

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Hans Guenter Drexler

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19148830

http://www.w3.org/2001/XMLSchema#string

P921